Global Pharmacogenetics Testing Market Growth (Status and Outlook) 2025-2031
The global Pharmacogenetics Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Pharmacogenetics testing is a type of genetic testing that analyzes an individual's genetic makeup to determine how they may respond to certain medications. It involves studying the variations in genes that affect drug metabolism, efficacy, and potential side effects.
Pharmacogenetics testing can provide valuable information to healthcare professionals in determining the most effective and safe medications for a particular individual. By understanding an individual's genetic variations, doctors can tailor drug prescriptions to match their specific genetic profile, potentially improving treatment outcomes and reducing the risk of adverse drug reactions.
This type of testing is particularly useful in determining the appropriate dosage of medications, predicting the likelihood of adverse drug reactions, and identifying individuals who may be poor responders to certain drugs. It can also help avoid trial-and-error approaches to medication selection, allowing for more personalized and precise treatment plans.
Pharmacogenetics testing is commonly used in various medical fields, including psychiatry, cardiology, oncology, and pain management. It is especially beneficial for medications with a narrow therapeutic index, where small variations in drug metabolism can significantly impact treatment outcomes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Pharmacogenetics Testing Industry Forecast” looks at past sales and reviews total world Pharmacogenetics Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmacogenetics Testing sales for 2025 through 2031. With Pharmacogenetics Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacogenetics Testing industry.
This Insight Report provides a comprehensive analysis of the global Pharmacogenetics Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmacogenetics Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmacogenetics Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacogenetics Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacogenetics Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacogenetics Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pharmacogenetics testing is a type of genetic testing that analyzes an individual's genetic makeup to determine how they may respond to certain medications. It involves studying the variations in genes that affect drug metabolism, efficacy, and potential side effects.
Pharmacogenetics testing can provide valuable information to healthcare professionals in determining the most effective and safe medications for a particular individual. By understanding an individual's genetic variations, doctors can tailor drug prescriptions to match their specific genetic profile, potentially improving treatment outcomes and reducing the risk of adverse drug reactions.
This type of testing is particularly useful in determining the appropriate dosage of medications, predicting the likelihood of adverse drug reactions, and identifying individuals who may be poor responders to certain drugs. It can also help avoid trial-and-error approaches to medication selection, allowing for more personalized and precise treatment plans.
Pharmacogenetics testing is commonly used in various medical fields, including psychiatry, cardiology, oncology, and pain management. It is especially beneficial for medications with a narrow therapeutic index, where small variations in drug metabolism can significantly impact treatment outcomes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Pharmacogenetics Testing Industry Forecast” looks at past sales and reviews total world Pharmacogenetics Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmacogenetics Testing sales for 2025 through 2031. With Pharmacogenetics Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacogenetics Testing industry.
This Insight Report provides a comprehensive analysis of the global Pharmacogenetics Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmacogenetics Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmacogenetics Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacogenetics Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacogenetics Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacogenetics Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Dosage Selection
- Adverse Reaction Assessment
- Enterprise
- Government
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Genetworx
- ARUP Laboratories
- Labcorp
- Invitae
- Clinical Labs
- Abomics
- Gravity Diagnostics
- Carolina Pharmacy
- Kailos Genetics
- Fulgent Genetics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmacogenetics Testing Market Size (2020-2031)
2.1.2 Pharmacogenetics Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmacogenetics Testing by Country/Region (2020, 2024 & 2031)
2.2 Pharmacogenetics Testing Segment by Type
2.2.1 Dosage Selection
2.2.2 Adverse Reaction Assessment
2.3 Pharmacogenetics Testing Market Size by Type
2.3.1 Pharmacogenetics Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmacogenetics Testing Market Size Market Share by Type (2020-2025)
2.4 Pharmacogenetics Testing Segment by Application
2.4.1 Enterprise
2.4.2 Government
2.5 Pharmacogenetics Testing Market Size by Application
2.5.1 Pharmacogenetics Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmacogenetics Testing Market Size Market Share by Application (2020-2025)
3 PHARMACOGENETICS TESTING MARKET SIZE BY PLAYER
3.1 Pharmacogenetics Testing Market Size Market Share by Player
3.1.1 Global Pharmacogenetics Testing Revenue by Player (2020-2025)
3.1.2 Global Pharmacogenetics Testing Revenue Market Share by Player (2020-2025)
3.2 Global Pharmacogenetics Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACOGENETICS TESTING BY REGION
4.1 Pharmacogenetics Testing Market Size by Region (2020-2025)
4.2 Global Pharmacogenetics Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmacogenetics Testing Market Size Growth (2020-2025)
4.4 APAC Pharmacogenetics Testing Market Size Growth (2020-2025)
4.5 Europe Pharmacogenetics Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmacogenetics Testing Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Pharmacogenetics Testing Market Size by Country (2020-2025)
5.2 Americas Pharmacogenetics Testing Market Size by Type (2020-2025)
5.3 Americas Pharmacogenetics Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacogenetics Testing Market Size by Region (2020-2025)
6.2 APAC Pharmacogenetics Testing Market Size by Type (2020-2025)
6.3 APAC Pharmacogenetics Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmacogenetics Testing Market Size by Country (2020-2025)
7.2 Europe Pharmacogenetics Testing Market Size by Type (2020-2025)
7.3 Europe Pharmacogenetics Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmacogenetics Testing by Region (2020-2025)
8.2 Middle East & Africa Pharmacogenetics Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmacogenetics Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACOGENETICS TESTING MARKET FORECAST
10.1 Global Pharmacogenetics Testing Forecast by Region (2026-2031)
10.1.1 Global Pharmacogenetics Testing Forecast by Region (2026-2031)
10.1.2 Americas Pharmacogenetics Testing Forecast
10.1.3 APAC Pharmacogenetics Testing Forecast
10.1.4 Europe Pharmacogenetics Testing Forecast
10.1.5 Middle East & Africa Pharmacogenetics Testing Forecast
10.2 Americas Pharmacogenetics Testing Forecast by Country (2026-2031)
10.2.1 United States Market Pharmacogenetics Testing Forecast
10.2.2 Canada Market Pharmacogenetics Testing Forecast
10.2.3 Mexico Market Pharmacogenetics Testing Forecast
10.2.4 Brazil Market Pharmacogenetics Testing Forecast
10.3 APAC Pharmacogenetics Testing Forecast by Region (2026-2031)
10.3.1 China Pharmacogenetics Testing Market Forecast
10.3.2 Japan Market Pharmacogenetics Testing Forecast
10.3.3 Korea Market Pharmacogenetics Testing Forecast
10.3.4 Southeast Asia Market Pharmacogenetics Testing Forecast
10.3.5 India Market Pharmacogenetics Testing Forecast
10.3.6 Australia Market Pharmacogenetics Testing Forecast
10.4 Europe Pharmacogenetics Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmacogenetics Testing Forecast
10.4.2 France Market Pharmacogenetics Testing Forecast
10.4.3 UK Market Pharmacogenetics Testing Forecast
10.4.4 Italy Market Pharmacogenetics Testing Forecast
10.4.5 Russia Market Pharmacogenetics Testing Forecast
10.5 Middle East & Africa Pharmacogenetics Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmacogenetics Testing Forecast
10.5.2 South Africa Market Pharmacogenetics Testing Forecast
10.5.3 Israel Market Pharmacogenetics Testing Forecast
10.5.4 Turkey Market Pharmacogenetics Testing Forecast
10.6 Global Pharmacogenetics Testing Forecast by Type (2026-2031)
10.7 Global Pharmacogenetics Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmacogenetics Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Genetworx
11.1.1 Genetworx Company Information
11.1.2 Genetworx Pharmacogenetics Testing Product Offered
11.1.3 Genetworx Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Genetworx Main Business Overview
11.1.5 Genetworx Latest Developments
11.2 ARUP Laboratories
11.2.1 ARUP Laboratories Company Information
11.2.2 ARUP Laboratories Pharmacogenetics Testing Product Offered
11.2.3 ARUP Laboratories Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 ARUP Laboratories Main Business Overview
11.2.5 ARUP Laboratories Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Pharmacogenetics Testing Product Offered
11.3.3 Labcorp Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 Invitae
11.4.1 Invitae Company Information
11.4.2 Invitae Pharmacogenetics Testing Product Offered
11.4.3 Invitae Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Invitae Main Business Overview
11.4.5 Invitae Latest Developments
11.5 Clinical Labs
11.5.1 Clinical Labs Company Information
11.5.2 Clinical Labs Pharmacogenetics Testing Product Offered
11.5.3 Clinical Labs Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Clinical Labs Main Business Overview
11.5.5 Clinical Labs Latest Developments
11.6 Abomics
11.6.1 Abomics Company Information
11.6.2 Abomics Pharmacogenetics Testing Product Offered
11.6.3 Abomics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Abomics Main Business Overview
11.6.5 Abomics Latest Developments
11.7 Gravity Diagnostics
11.7.1 Gravity Diagnostics Company Information
11.7.2 Gravity Diagnostics Pharmacogenetics Testing Product Offered
11.7.3 Gravity Diagnostics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Gravity Diagnostics Main Business Overview
11.7.5 Gravity Diagnostics Latest Developments
11.8 Carolina Pharmacy
11.8.1 Carolina Pharmacy Company Information
11.8.2 Carolina Pharmacy Pharmacogenetics Testing Product Offered
11.8.3 Carolina Pharmacy Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Carolina Pharmacy Main Business Overview
11.8.5 Carolina Pharmacy Latest Developments
11.9 Kailos Genetics
11.9.1 Kailos Genetics Company Information
11.9.2 Kailos Genetics Pharmacogenetics Testing Product Offered
11.9.3 Kailos Genetics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Kailos Genetics Main Business Overview
11.9.5 Kailos Genetics Latest Developments
11.10 Fulgent Genetics
11.10.1 Fulgent Genetics Company Information
11.10.2 Fulgent Genetics Pharmacogenetics Testing Product Offered
11.10.3 Fulgent Genetics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Fulgent Genetics Main Business Overview
11.10.5 Fulgent Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. PharmacogeneticsTesting Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. PharmacogeneticsTesting Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dosage Selection
Table 4. Major Players of Adverse Reaction Assessment
Table 5. PharmacogeneticsTesting Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 7. Global PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Table 8. PharmacogeneticsTesting Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 10. Global PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Table 11. Global PharmacogeneticsTesting Revenue by Player (2020-2025) & ($ millions)
Table 12. Global PharmacogeneticsTesting Revenue Market Share by Player (2020-2025)
Table 13. PharmacogeneticsTesting Key Players Head office and Products Offered
Table 14. PharmacogeneticsTesting Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global PharmacogeneticsTesting Market Size by Region (2020-2025) & ($ millions)
Table 18. Global PharmacogeneticsTesting Market Size Market Share by Region (2020-2025)
Table 19. Global PharmacogeneticsTesting Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global PharmacogeneticsTesting Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas PharmacogeneticsTesting Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas PharmacogeneticsTesting Market Size Market Share by Country (2020-2025)
Table 23. Americas PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 24. Americas PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Table 25. Americas PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Table 27. APAC PharmacogeneticsTesting Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC PharmacogeneticsTesting Market Size Market Share by Region (2020-2025)
Table 29. APAC PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 30. APAC PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe PharmacogeneticsTesting Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe PharmacogeneticsTesting Market Size Market Share by Country (2020-2025)
Table 33. Europe PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 34. Europe PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa PharmacogeneticsTesting Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of PharmacogeneticsTesting
Table 39. Key Market Challenges & Risks of PharmacogeneticsTesting
Table 40. Key IndustryTrends of PharmacogeneticsTesting
Table 41. Global PharmacogeneticsTesting Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global PharmacogeneticsTesting Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global PharmacogeneticsTesting Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global PharmacogeneticsTesting Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Genetworx Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 46. Genetworx PharmacogeneticsTesting Product Offered
Table 47. Genetworx PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Genetworx Main Business
Table 49. Genetworx Latest Developments
Table 50. ARUP Laboratories Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 51. ARUP Laboratories PharmacogeneticsTesting Product Offered
Table 52. ARUP Laboratories PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. ARUP Laboratories Main Business
Table 54. ARUP Laboratories Latest Developments
Table 55. Labcorp Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 56. Labcorp PharmacogeneticsTesting Product Offered
Table 57. Labcorp PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Labcorp Main Business
Table 59. Labcorp Latest Developments
Table 60. Invitae Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 61. Invitae PharmacogeneticsTesting Product Offered
Table 62. Invitae PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Invitae Main Business
Table 64. Invitae Latest Developments
Table 65. Clinical Labs Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 66. Clinical Labs PharmacogeneticsTesting Product Offered
Table 67. Clinical Labs PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Clinical Labs Main Business
Table 69. Clinical Labs Latest Developments
Table 70. Abomics Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 71. Abomics PharmacogeneticsTesting Product Offered
Table 72. Abomics PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Abomics Main Business
Table 74. Abomics Latest Developments
Table 75. Gravity Diagnostics Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 76. Gravity Diagnostics PharmacogeneticsTesting Product Offered
Table 77. Gravity Diagnostics PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Gravity Diagnostics Main Business
Table 79. Gravity Diagnostics Latest Developments
Table 80. Carolina Pharmacy Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 81. Carolina Pharmacy PharmacogeneticsTesting Product Offered
Table 82. Carolina Pharmacy PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Carolina Pharmacy Main Business
Table 84. Carolina Pharmacy Latest Developments
Table 85. Kailos Genetics Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 86. Kailos Genetics PharmacogeneticsTesting Product Offered
Table 87. Kailos Genetics PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Kailos Genetics Main Business
Table 89. Kailos Genetics Latest Developments
Table 90.Fulgent Genetics Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 91.Fulgent Genetics PharmacogeneticsTesting Product Offered
Table 92.Fulgent Genetics PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93.Fulgent Genetics Main Business
Table 94.Fulgent Genetics Latest Developments
LIST OFFIGURES
Figure 1. PharmacogeneticsTesting Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PharmacogeneticsTesting Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. PharmacogeneticsTesting Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. PharmacogeneticsTesting Sales Market Share by Country/Region (2024)
Figure 8. PharmacogeneticsTesting Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global PharmacogeneticsTesting Market Size Market Share byType in 2024
Figure 10. PharmacogeneticsTesting in Enterprise
Figure 11. Global PharmacogeneticsTesting Market: Enterprise (2020-2025) & ($ millions)
Figure 12. PharmacogeneticsTesting in Government
Figure 13. Global PharmacogeneticsTesting Market: Government (2020-2025) & ($ millions)
Figure 14. Global PharmacogeneticsTesting Market Size Market Share by Application in 2024
Figure 15. Global PharmacogeneticsTesting Revenue Market Share by Player in 2024
Figure 16. Global PharmacogeneticsTesting Market Size Market Share by Region (2020-2025)
Figure 17. Americas PharmacogeneticsTesting Market Size 2020-2025 ($ millions)
Figure 18. APAC PharmacogeneticsTesting Market Size 2020-2025 ($ millions)
Figure 19. Europe PharmacogeneticsTesting Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa PharmacogeneticsTesting Market Size 2020-2025 ($ millions)
Figure 21. Americas PharmacogeneticsTesting Value Market Share by Country in 2024
Figure 22. United States PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC PharmacogeneticsTesting Market Size Market Share by Region in 2024
Figure 27. APAC PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Figure 28. APAC PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Figure 29. China PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 33. India PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe PharmacogeneticsTesting Market Size Market Share by Country in 2024
Figure 36. Europe PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Figure 37. Europe PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Figure 38. Germany PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 39.France PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 40. UK PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa PharmacogeneticsTesting Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Figure 46. Egypt PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 52. APAC PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 53. Europe PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 55. United States PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 56. Canada PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 57. Mexico PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 58. Brazil PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 59. China PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 60. Japan PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 61. Korea PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 63. India PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 64. Australia PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 65. Germany PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 66.France PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 67. UK PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 68. Italy PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 69. Russia PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 70. Egypt PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 71. South Africa PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 72. Israel PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 73.Turkey PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 74. Global PharmacogeneticsTesting Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global PharmacogeneticsTesting Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmacogenetics Testing Market Size (2020-2031)
2.1.2 Pharmacogenetics Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmacogenetics Testing by Country/Region (2020, 2024 & 2031)
2.2 Pharmacogenetics Testing Segment by Type
2.2.1 Dosage Selection
2.2.2 Adverse Reaction Assessment
2.3 Pharmacogenetics Testing Market Size by Type
2.3.1 Pharmacogenetics Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmacogenetics Testing Market Size Market Share by Type (2020-2025)
2.4 Pharmacogenetics Testing Segment by Application
2.4.1 Enterprise
2.4.2 Government
2.5 Pharmacogenetics Testing Market Size by Application
2.5.1 Pharmacogenetics Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmacogenetics Testing Market Size Market Share by Application (2020-2025)
3 PHARMACOGENETICS TESTING MARKET SIZE BY PLAYER
3.1 Pharmacogenetics Testing Market Size Market Share by Player
3.1.1 Global Pharmacogenetics Testing Revenue by Player (2020-2025)
3.1.2 Global Pharmacogenetics Testing Revenue Market Share by Player (2020-2025)
3.2 Global Pharmacogenetics Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACOGENETICS TESTING BY REGION
4.1 Pharmacogenetics Testing Market Size by Region (2020-2025)
4.2 Global Pharmacogenetics Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmacogenetics Testing Market Size Growth (2020-2025)
4.4 APAC Pharmacogenetics Testing Market Size Growth (2020-2025)
4.5 Europe Pharmacogenetics Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmacogenetics Testing Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Pharmacogenetics Testing Market Size by Country (2020-2025)
5.2 Americas Pharmacogenetics Testing Market Size by Type (2020-2025)
5.3 Americas Pharmacogenetics Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacogenetics Testing Market Size by Region (2020-2025)
6.2 APAC Pharmacogenetics Testing Market Size by Type (2020-2025)
6.3 APAC Pharmacogenetics Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmacogenetics Testing Market Size by Country (2020-2025)
7.2 Europe Pharmacogenetics Testing Market Size by Type (2020-2025)
7.3 Europe Pharmacogenetics Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmacogenetics Testing by Region (2020-2025)
8.2 Middle East & Africa Pharmacogenetics Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmacogenetics Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACOGENETICS TESTING MARKET FORECAST
10.1 Global Pharmacogenetics Testing Forecast by Region (2026-2031)
10.1.1 Global Pharmacogenetics Testing Forecast by Region (2026-2031)
10.1.2 Americas Pharmacogenetics Testing Forecast
10.1.3 APAC Pharmacogenetics Testing Forecast
10.1.4 Europe Pharmacogenetics Testing Forecast
10.1.5 Middle East & Africa Pharmacogenetics Testing Forecast
10.2 Americas Pharmacogenetics Testing Forecast by Country (2026-2031)
10.2.1 United States Market Pharmacogenetics Testing Forecast
10.2.2 Canada Market Pharmacogenetics Testing Forecast
10.2.3 Mexico Market Pharmacogenetics Testing Forecast
10.2.4 Brazil Market Pharmacogenetics Testing Forecast
10.3 APAC Pharmacogenetics Testing Forecast by Region (2026-2031)
10.3.1 China Pharmacogenetics Testing Market Forecast
10.3.2 Japan Market Pharmacogenetics Testing Forecast
10.3.3 Korea Market Pharmacogenetics Testing Forecast
10.3.4 Southeast Asia Market Pharmacogenetics Testing Forecast
10.3.5 India Market Pharmacogenetics Testing Forecast
10.3.6 Australia Market Pharmacogenetics Testing Forecast
10.4 Europe Pharmacogenetics Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmacogenetics Testing Forecast
10.4.2 France Market Pharmacogenetics Testing Forecast
10.4.3 UK Market Pharmacogenetics Testing Forecast
10.4.4 Italy Market Pharmacogenetics Testing Forecast
10.4.5 Russia Market Pharmacogenetics Testing Forecast
10.5 Middle East & Africa Pharmacogenetics Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmacogenetics Testing Forecast
10.5.2 South Africa Market Pharmacogenetics Testing Forecast
10.5.3 Israel Market Pharmacogenetics Testing Forecast
10.5.4 Turkey Market Pharmacogenetics Testing Forecast
10.6 Global Pharmacogenetics Testing Forecast by Type (2026-2031)
10.7 Global Pharmacogenetics Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmacogenetics Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Genetworx
11.1.1 Genetworx Company Information
11.1.2 Genetworx Pharmacogenetics Testing Product Offered
11.1.3 Genetworx Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Genetworx Main Business Overview
11.1.5 Genetworx Latest Developments
11.2 ARUP Laboratories
11.2.1 ARUP Laboratories Company Information
11.2.2 ARUP Laboratories Pharmacogenetics Testing Product Offered
11.2.3 ARUP Laboratories Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 ARUP Laboratories Main Business Overview
11.2.5 ARUP Laboratories Latest Developments
11.3 Labcorp
11.3.1 Labcorp Company Information
11.3.2 Labcorp Pharmacogenetics Testing Product Offered
11.3.3 Labcorp Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Labcorp Main Business Overview
11.3.5 Labcorp Latest Developments
11.4 Invitae
11.4.1 Invitae Company Information
11.4.2 Invitae Pharmacogenetics Testing Product Offered
11.4.3 Invitae Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Invitae Main Business Overview
11.4.5 Invitae Latest Developments
11.5 Clinical Labs
11.5.1 Clinical Labs Company Information
11.5.2 Clinical Labs Pharmacogenetics Testing Product Offered
11.5.3 Clinical Labs Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Clinical Labs Main Business Overview
11.5.5 Clinical Labs Latest Developments
11.6 Abomics
11.6.1 Abomics Company Information
11.6.2 Abomics Pharmacogenetics Testing Product Offered
11.6.3 Abomics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Abomics Main Business Overview
11.6.5 Abomics Latest Developments
11.7 Gravity Diagnostics
11.7.1 Gravity Diagnostics Company Information
11.7.2 Gravity Diagnostics Pharmacogenetics Testing Product Offered
11.7.3 Gravity Diagnostics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Gravity Diagnostics Main Business Overview
11.7.5 Gravity Diagnostics Latest Developments
11.8 Carolina Pharmacy
11.8.1 Carolina Pharmacy Company Information
11.8.2 Carolina Pharmacy Pharmacogenetics Testing Product Offered
11.8.3 Carolina Pharmacy Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Carolina Pharmacy Main Business Overview
11.8.5 Carolina Pharmacy Latest Developments
11.9 Kailos Genetics
11.9.1 Kailos Genetics Company Information
11.9.2 Kailos Genetics Pharmacogenetics Testing Product Offered
11.9.3 Kailos Genetics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Kailos Genetics Main Business Overview
11.9.5 Kailos Genetics Latest Developments
11.10 Fulgent Genetics
11.10.1 Fulgent Genetics Company Information
11.10.2 Fulgent Genetics Pharmacogenetics Testing Product Offered
11.10.3 Fulgent Genetics Pharmacogenetics Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Fulgent Genetics Main Business Overview
11.10.5 Fulgent Genetics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. PharmacogeneticsTesting Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. PharmacogeneticsTesting Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Dosage Selection
Table 4. Major Players of Adverse Reaction Assessment
Table 5. PharmacogeneticsTesting Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 7. Global PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Table 8. PharmacogeneticsTesting Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 10. Global PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Table 11. Global PharmacogeneticsTesting Revenue by Player (2020-2025) & ($ millions)
Table 12. Global PharmacogeneticsTesting Revenue Market Share by Player (2020-2025)
Table 13. PharmacogeneticsTesting Key Players Head office and Products Offered
Table 14. PharmacogeneticsTesting Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global PharmacogeneticsTesting Market Size by Region (2020-2025) & ($ millions)
Table 18. Global PharmacogeneticsTesting Market Size Market Share by Region (2020-2025)
Table 19. Global PharmacogeneticsTesting Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global PharmacogeneticsTesting Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas PharmacogeneticsTesting Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas PharmacogeneticsTesting Market Size Market Share by Country (2020-2025)
Table 23. Americas PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 24. Americas PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Table 25. Americas PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Table 27. APAC PharmacogeneticsTesting Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC PharmacogeneticsTesting Market Size Market Share by Region (2020-2025)
Table 29. APAC PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 30. APAC PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe PharmacogeneticsTesting Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe PharmacogeneticsTesting Market Size Market Share by Country (2020-2025)
Table 33. Europe PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 34. Europe PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa PharmacogeneticsTesting Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa PharmacogeneticsTesting Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa PharmacogeneticsTesting Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of PharmacogeneticsTesting
Table 39. Key Market Challenges & Risks of PharmacogeneticsTesting
Table 40. Key IndustryTrends of PharmacogeneticsTesting
Table 41. Global PharmacogeneticsTesting Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global PharmacogeneticsTesting Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global PharmacogeneticsTesting Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global PharmacogeneticsTesting Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Genetworx Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 46. Genetworx PharmacogeneticsTesting Product Offered
Table 47. Genetworx PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Genetworx Main Business
Table 49. Genetworx Latest Developments
Table 50. ARUP Laboratories Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 51. ARUP Laboratories PharmacogeneticsTesting Product Offered
Table 52. ARUP Laboratories PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. ARUP Laboratories Main Business
Table 54. ARUP Laboratories Latest Developments
Table 55. Labcorp Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 56. Labcorp PharmacogeneticsTesting Product Offered
Table 57. Labcorp PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Labcorp Main Business
Table 59. Labcorp Latest Developments
Table 60. Invitae Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 61. Invitae PharmacogeneticsTesting Product Offered
Table 62. Invitae PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Invitae Main Business
Table 64. Invitae Latest Developments
Table 65. Clinical Labs Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 66. Clinical Labs PharmacogeneticsTesting Product Offered
Table 67. Clinical Labs PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Clinical Labs Main Business
Table 69. Clinical Labs Latest Developments
Table 70. Abomics Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 71. Abomics PharmacogeneticsTesting Product Offered
Table 72. Abomics PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Abomics Main Business
Table 74. Abomics Latest Developments
Table 75. Gravity Diagnostics Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 76. Gravity Diagnostics PharmacogeneticsTesting Product Offered
Table 77. Gravity Diagnostics PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Gravity Diagnostics Main Business
Table 79. Gravity Diagnostics Latest Developments
Table 80. Carolina Pharmacy Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 81. Carolina Pharmacy PharmacogeneticsTesting Product Offered
Table 82. Carolina Pharmacy PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Carolina Pharmacy Main Business
Table 84. Carolina Pharmacy Latest Developments
Table 85. Kailos Genetics Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 86. Kailos Genetics PharmacogeneticsTesting Product Offered
Table 87. Kailos Genetics PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Kailos Genetics Main Business
Table 89. Kailos Genetics Latest Developments
Table 90.Fulgent Genetics Details, CompanyType, PharmacogeneticsTesting Area Served and Its Competitors
Table 91.Fulgent Genetics PharmacogeneticsTesting Product Offered
Table 92.Fulgent Genetics PharmacogeneticsTesting Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93.Fulgent Genetics Main Business
Table 94.Fulgent Genetics Latest Developments
LIST OFFIGURES
Figure 1. PharmacogeneticsTesting Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PharmacogeneticsTesting Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. PharmacogeneticsTesting Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. PharmacogeneticsTesting Sales Market Share by Country/Region (2024)
Figure 8. PharmacogeneticsTesting Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global PharmacogeneticsTesting Market Size Market Share byType in 2024
Figure 10. PharmacogeneticsTesting in Enterprise
Figure 11. Global PharmacogeneticsTesting Market: Enterprise (2020-2025) & ($ millions)
Figure 12. PharmacogeneticsTesting in Government
Figure 13. Global PharmacogeneticsTesting Market: Government (2020-2025) & ($ millions)
Figure 14. Global PharmacogeneticsTesting Market Size Market Share by Application in 2024
Figure 15. Global PharmacogeneticsTesting Revenue Market Share by Player in 2024
Figure 16. Global PharmacogeneticsTesting Market Size Market Share by Region (2020-2025)
Figure 17. Americas PharmacogeneticsTesting Market Size 2020-2025 ($ millions)
Figure 18. APAC PharmacogeneticsTesting Market Size 2020-2025 ($ millions)
Figure 19. Europe PharmacogeneticsTesting Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa PharmacogeneticsTesting Market Size 2020-2025 ($ millions)
Figure 21. Americas PharmacogeneticsTesting Value Market Share by Country in 2024
Figure 22. United States PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC PharmacogeneticsTesting Market Size Market Share by Region in 2024
Figure 27. APAC PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Figure 28. APAC PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Figure 29. China PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 33. India PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe PharmacogeneticsTesting Market Size Market Share by Country in 2024
Figure 36. Europe PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Figure 37. Europe PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Figure 38. Germany PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 39.France PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 40. UK PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa PharmacogeneticsTesting Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa PharmacogeneticsTesting Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa PharmacogeneticsTesting Market Size Market Share by Application (2020-2025)
Figure 46. Egypt PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries PharmacogeneticsTesting Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 52. APAC PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 53. Europe PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 55. United States PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 56. Canada PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 57. Mexico PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 58. Brazil PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 59. China PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 60. Japan PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 61. Korea PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 63. India PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 64. Australia PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 65. Germany PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 66.France PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 67. UK PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 68. Italy PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 69. Russia PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 70. Egypt PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 71. South Africa PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 72. Israel PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 73.Turkey PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
Figure 74. Global PharmacogeneticsTesting Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global PharmacogeneticsTesting Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries PharmacogeneticsTesting Market Size 2026-2031 ($ millions)
More Publications
Global Biomedical Imaging Technologies Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
92 pages
Global Copper Graphite Brushes Market Growth 2025-2031
US$ 3,660.00
November 2025
78 pages
Global 5G mmWave Chipset Market Growth 2026-2032
US$ 3,660.00
July 2026
121 pages
Global Lead Type Capacitors Market Growth 2025-2031
US$ 3,660.00
November 2025
121 pages
Global Corporate Finance Strategy Consulting Services Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
October 2024
106 pages
